XANAX 0.5mg Price

Overview

Welcome to Dwaey, specifically on XANAX 0.5mg Tablets page.
This medicine contains an important and useful components, as it consists of Alprazolam.
XANAX 0.5mg is available in the market in concentration 0.5mg/Tablet and in the form of Tablets.

PFIZER ITALIA S.r.l. is the producer of XANAX 0.5mg and it is imported from ITALY, The most popular alternatives of XANAX 0.5mg are listed downward .

Mode Of Action

Alprazolam has anxiolytic, muscle-relaxant, anticonvulsant, antidepressant and sleep-modifying effects. It binds to the ? aminobutyric acid (GABA)-specific sites throughout the CNS, leading to an increase in the inhibitory effect of GABA on neuronal excitability. Increased neuronal permeability to chloride ions thus results in hyperpolarisation and stabilisation.

Indication

• Anxiety disorders
• Panic disorders
• Nausea due to chemotherapy

Precaution

Dosage reduction or gradual withdrawal. Dependence. Geriatric or debilitated patients. Muscle weakness, impaired hepatic or renal function; arteriosclerosis; obesity; depression particularly suicidal tendency; chronic pulmonary insufficiency. May impair ability to drive or operate machinery. Children <18 yr. Lactation: Enters breast milk/not recommended

Side Effects

• >10% (4 mg dose) Drowsiness (41%)
• Depression (10-15%)
• Headache (10-15%)
• Constipation (10-15%)
• Diarrhea (10-15%)
• Dry mouth (10-15%) >10% (10 mg dose) Drowsiness (77%)
• Impaired coordination (40-50%)
• Increased appetite (30-35%)
• Fatigue (30-35%)
• Memory impairment (30-35%)
• Irritability (30-35%)
• Decreased salivation (30-35%)
• Cognitive disorders (20-30%)
• Insomnia (20-30%)
• Dcreased appetite (20-30%)
• Headache (20-30%)
• Lightheadedness (20-30%)
• Dysarthria (20-30%)
• Diarrhea
• constipation
• and nausea/vomiting (20-30%)
• Weight change (20-30%)
• Nasal congestion (15-20%)
• Decreased or increased libido (10-15%)
• Menstrual disorder (10-15%)
• Difficult micturition (10-15%) 1-10% (4 mg dose) Tachycardia (5-10%)
• Confusion (5-10%)
• Insomnia (5-10%)
• Nausea/vomiting (5-10%)
• Blurred vision (5-10%)
• Nasal congestion (5-10%)
• Hypotension (1-5%)
• Syncope (1-5%)
• Akathisia (1-5%)
• Dizziness (1-5%)
• Increased salivation (1-5%)
• Nervousness (1-5%)
• Tremor (1-5%)
• Weight change (1-5%) 1-10% (10 mg dose) Increased salivation (5-10%)
• Talkativeness (1-5%)
• Incontinence (1-5%) Potentially Fatal: Blood dyscrasias.

Contra indication

Acute narrow-angle glaucoma, preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; pregnancy, lactation.

Pregnancy and lactation

Pregnancy category: D

There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.